Bumble Inc vs Enveric Biosciences Inc — how do they compare? Bumble Inc trades at $3 (market cap $406.29M), while Enveric Biosciences Inc trades at $1.25 (market cap $5.36M). The key difference: Bumble Inc is far larger — about 75.8× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| BMBL | ENVB | |
|---|---|---|
Market Cap | $406.29M | $5.36M |
Sector | Technology | Health |
52-Week High | $8.57 | $17.40 |
52-Week Low | $2.70 | $1.28 |
Enterprise Value | $757.97M | $449.11K |
Signals from Pluang's Aura AI — not financial advice
BMBL trades at $3.11, up 2.64% over 24 hours, with a neutral technical signal and bearish moving averages. The company reported a Q1 2026 EPS beat but faces declining revenue and a net loss of -$693.14M for 2025. Recent news highlights a potential sale exploration and an AI-driven product overhaul to counter slowing growth and payer declines.
Outlook remains speculative with a consensus price target of $4.37, offering 40% upside, but risks include persistent losses, high debt, and intense competition. Execution of the strategic reset is critical for a turnaround, with cash flow improvements providing a slight cushion amid operational challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
Bumble Inc is engaged in offering online dating services. The company operates two apps, Bumble and Badoo, where users come on a monthly basis to discover new people and connect with each other.
Read more on BMBL →Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →